Malignant hypertension overview: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 5: Line 5:


Malignant hypertension is a complication of [[hypertension]] characterized by very elevated [[blood pressure]], and organ damage in the [[eye]]s, [[brain]], [[lung]] and/or [[kidney]]s. It differs from other complications of hypertension in that it is accompanied by [[papilledema]]. [[Systolic]] and [[diastolic]] [[blood pressure]]s are usually greater than 200 and 140, respectively.
Malignant hypertension is a complication of [[hypertension]] characterized by very elevated [[blood pressure]], and organ damage in the [[eye]]s, [[brain]], [[lung]] and/or [[kidney]]s. It differs from other complications of hypertension in that it is accompanied by [[papilledema]]. [[Systolic]] and [[diastolic]] [[blood pressure]]s are usually greater than 200 and 140, respectively.
==Diagnosis==
===Electrocardiogram===
The ECG is necessary to screen for ischemia, infarct, or evidence of electrolyte abnormalities or drug overdose.


==References==
==References==

Revision as of 20:17, 22 February 2013

Malignant hypertension Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Malignant hypertension from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Malignant hypertension overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Malignant hypertension overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Malignant hypertension overview

CDC on Malignant hypertension overview

Malignant hypertension overview in the news

Blogs on Malignant hypertension overview

Directions to Hospitals Treating Malignant hypertension

Risk calculators and risk factors for Malignant hypertension overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Malignant hypertension is a complication of hypertension characterized by very elevated blood pressure, and organ damage in the eyes, brain, lung and/or kidneys. It differs from other complications of hypertension in that it is accompanied by papilledema. Systolic and diastolic blood pressures are usually greater than 200 and 140, respectively.

Diagnosis

Electrocardiogram

The ECG is necessary to screen for ischemia, infarct, or evidence of electrolyte abnormalities or drug overdose.

References


Template:WikiDoc Sources